Novo Nordisk targets -2% to +2% 2026 sales growth at CER while expecting DKK 60B to DKK 70B free cash flow

Seeking Alpha · 市场快讯 · November 4, 2026 at 2:05 PM ET

Read the full report at the original publisher.